Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573270 · ClinicalTrials.gov registry record · Phase 1
Mesenchymal Stem Cells for the Treatment of COVID-19
A Phase 1 study, sponsored by Thomas Advanced Medical.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT04573270 is a Phase 1 study that has completed, run by Thomas Advanced Medical. The registered enrollment target is 40 participants.
The verdict
NCT04573270, a Phase 1 study, has completed, sponsored by Thomas Advanced Medical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This double blind, placebo controlled, multi-arm, multi-site study investigates the safety and efficacy of stem cell therapy for the treatment of patients admitted to hospital suffering complications from COVID-19 and the treatment of healthy subjects (healthcare providers) for prophylactic effect following those patients.
Interventions
- OTHER Placebo
- BIOLOGICAL PrimePro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2020-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04573270
The ClinicalTrials.gov registry entry for NCT04573270 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Advanced Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04573270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04573270 about?
NCT04573270 is a clinical study titled "Mesenchymal Stem Cells for the Treatment of COVID-19". This double blind, placebo controlled, multi-arm, multi-site study investigates the safety and efficacy of stem cell therapy for the treatment of patients admitted to hospital suffering complications from COVID-19 and the treatment of healthy subjects (healthcare providers) for prophylactic effect f...
What is the current status of trial NCT04573270?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2020-04-24. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT04573270?
The interventions under investigation include: Placebo (OTHER), PrimePro (BIOLOGICAL).
Who is sponsoring clinical trial NCT04573270?
This trial is sponsored by Thomas Advanced Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.